Cervical cancer is largely preventable, yet it continues to place a disproportionate burden on women across Asia. The re...
West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, has anno...
QIAGEN, a global provider of Sample to Insight solutions, has officially commenced a new distribution partnership with H...
Artificial intelligence is rapidly reshaping the way biopharma companies discover, develop, and manufacture medicines. H...
As cell and gene therapies progress from promising research to commercial reality, manufacturing has emerged as ...
As antibody-drug conjugates (ADCs) transition from a promising therapeutic modality to a cornerstone of precision oncolo...
As antibody-drug conjugates (ADCs), bispecific antibodies and other advanced biologics redefine the global therapeutics ...
The rapid expansion of in vivo gene therapy is reshaping expectations for viral vector manufacturing, placing greater em...
The Role of Regulatory Classification The foundation of any medical device development project is understanding...
China-based CanSino Biologics Inc. has announced that the company's ACYW135 Meningococcal Polysaccharide Conjugate Vacci...
Viral hepatitis remains a leading global health problem, with hepatitis B (HBV) and hepatitis C (HCV), accounting for 95...
Research institutions generate groundbreaking discoveries every year, yet only a small fraction successfully reach patie...
Despite causing millions of serious infections and hundreds of thousands of deaths each year, fungal diseases continue t...
Cincinnati's life sciences ecosystem is gaining momentum through a unique combination of scientific excellence, collabor...
Oklahoma City's life sciences ambitions are increasingly centred on advanced manufacturing, collaboration, and long-term...
During BIO 2026 in San Diego, BioSpectrum Asia spoke with Kurt Imhof, Senior Vice President, Policy & Public Affairs...
During the BIO International Convention 2026 (June 22–25) in San Diego, BioSpectrum Asia spoke with Arthur Jackson...
During the BIO International Convention 2026 (June 22–25) in San Diego, BioSpectrum Asia spoke with Lan Nguyen, Ch...
During the BIO International Convention 2026 (June 22–25) in San Diego, BioSpectrum Asia spoke with Ella Woger-Nie...
While most cardiovascular research has traditionally focused on the heart and large blood vessels, a growing body of evi...
As obesity treatment enters a new phase of innovation, the industry is increasingly looking beyond GLP-1 therapies to ad...
As the pharmaceutical industry advances towards increasingly complex, poorly soluble drug candidates, formulation has ...
As obesity treatment evolves beyond weight loss toward comprehensive cardiometabolic disease management, pharmaceutical ...
There's a particular sound a convention floor makes when an industry has decided to stop apologising for itself....
Few therapeutic areas have witnessed the level of progress achieved in HIV over the past three decades...
